Insomnia
Chronic difficulty falling or staying asleep isn't just a matter of 'sleep hygiene' — the best-studied intervention, recommended as first-line treatment, is cognitive behavioral therapy for insomnia (CBT-I), not sleeping pills.
Number of studies
1
Safety
Moderate
Time to effects
In the studies covered by the Trauer et al. meta-analysis, improvement was assessed after completing a CBT-I program, typically lasting 4 to 8 weeks of regular sessions, with effects sustained in long-term follow-up.
Who it's for
Table of contents
TL;DR
Chronic difficulty falling or staying asleep isn't just a matter of 'sleep hygiene' — the best-studied intervention, recommended as first-line treatment, is cognitive behavioral therapy for insomnia (CBT-I), not sleeping pills.
- →CBT-I produces clinically meaningful improvement in sleep onset latency, wake time after sleep onset, and sleep efficiency
- →CBT-I's effects are sustained in long-term follow-up, unlike the effect of sleep medication after discontinuation
- →Carries no risk of pharmacological dependence or the rebound effect typical of some sleep medications
| Condition type | Sleep disorder — chronic difficulty falling asleep or staying asleep |
|---|---|
| Level of evidence | Strong — meta-analyses of randomized trials, first-line recommendation in clinical guidelines |
| Target group | People with chronic sleep difficulties, especially after sleep hygiene alone has failed |
| Diagnostic criteria | Symptoms at least 3x/week for at least 3 months, with impaired daytime functioning |
| First-line treatment | Cognitive behavioral therapy for insomnia (CBT-I), not sleep medication |
| Status | A recognized clinical disorder that, in its chronic form, requires structured intervention |
Understand
Overview
Insomnia is a sleep disorder characterized by persistent difficulty falling asleep, staying asleep, or waking too early despite adequate conditions for sleep, accompanied by impaired daytime functioning. When symptoms occur at least three times a week for a minimum of three months, this is called chronic insomnia, distinguished from short-term situational insomnia triggered by, say, stress, time-zone change, or illness — the latter usually resolves on its own once the cause passes.
For decades, the standard approach to treating insomnia was sleep medication, but current clinical guidelines, including those from American and European sleep medicine societies, recommend cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment — a structured program combining sleep restriction, stimulus control, cognitive restructuring, and sleep education. A 2015 meta-analysis by Trauer and colleagues, published in the prestigious Annals of Internal Medicine, analyzed 20 randomized trials comparing CBT-I to control groups (1,162 participants in total) and found clinically meaningful improvement across all major sleep parameters: sleep onset latency shortened by an average of 19 minutes, wake time after sleep onset decreased by 26 minutes, and sleep efficiency rose by nearly 10 percentage points — with effects sustained in long-term follow-up and no reported adverse effects.
Who might genuinely benefit from this knowledge? Anyone struggling with chronic sleep difficulties, especially those who have already tried basic sleep hygiene principles without lasting improvement — CBT-I addresses the deeper behavioral and cognitive mechanisms that sustain insomnia, not just surface-level habits. It's worth emphasizing that CBT-I, unlike sleep medication, carries no risk of dependence or rebound effect after discontinuation, making it a particularly valuable option for people seeking a long-term, not just a stopgap, solution.
Mechanism of action
Chronic insomnia often persists not so much because of the original cause that triggered it, but through secondary behavioral and cognitive mechanisms that sustain it — a model described by the so-called three-factor theory (predisposing, precipitating, and perpetuating factors). People with insomnia often develop unfavorable associations between the bed and wakefulness (e.g., lying awake for hours, worrying about sleep), which paradoxically heightens physiological and cognitive arousal exactly when the body should be winding down — a phenomenon called hyperarousal. CBT-I targets these mechanisms directly: sleep restriction temporarily narrows the sleep window, building stronger, more concentrated 'sleep pressure' (described in more depth in our sleep entry), while stimulus control restores the bed's association with sleep alone, not with wakeful lying or other activities.
Cognitive restructuring, another pillar of CBT-I, addresses catastrophizing, anxious thoughts about sleep ('if I don't fall asleep now, I'll be completely unable to function tomorrow'), which themselves heighten arousal and make falling asleep harder, creating a vicious circle. Unlike sleep medication, which suppresses symptoms pharmacologically without addressing the underlying behavioral mechanisms, CBT-I trains lasting changes in how the brain and body respond to bedtime — which explains why effects persist long-term after therapy ends, unlike medication effects, which usually fade once the drug is discontinued.
Development of unfavorable bed-wakefulness associations
Repeated episodes of lying awake in bed strengthen the association of bed with wakefulness rather than sleep.
Cognitive and physiological hyperarousal
Anxious thoughts about being unable to sleep heighten arousal exactly when the body should be winding down.
Sleep restriction and stimulus control (CBT-I)
Behavioral techniques rebuild strong sleep pressure and restore the bed's association with sleep alone.
Cognitive restructuring
Addressing catastrophizing thoughts about sleep breaks the vicious circle of anxiety and arousal that sustains insomnia.
Evidence: strong — based on 1 study in this database.
Benefits
Common myths
MythSleep medication is the most effective solution for chronic insomnia.
FactCurrent clinical guidelines recommend CBT-I as first-line treatment — meta-analyses show clinically meaningful, long-term sustained effects, without the dependence risk typical of some sleep medications.
MythImproving sleep hygiene alone is enough to cure chronic insomnia.
FactBasic sleep hygiene can be helpful, but with chronic insomnia it's often insufficient on its own — the key perpetuating mechanisms (unfavorable associations, anxious thoughts about sleep) require the structured intervention that CBT-I provides.
Personalized for you
Struggling with sleep?
Answer a few questions about your sleep, stress, diet, and lifestyle. VitMode will show you which areas might need the most attention and which supplements could be worth considering.
Recommendations take your answers and the strength of the scientific evidence into account. A supplement's popularity has no bearing on whether it gets recommended.
Practice
Frequently asked questions
Short-term insomnia is usually triggered by a specific, temporary cause (stress, time-zone change) and resolves on its own. Chronic insomnia is diagnosed when symptoms persist at least 3 times a week for a minimum of 3 months.
Self-help programs and apps based on CBT-I principles exist and have shown effectiveness in some studies, though working with a qualified therapist remains the best-studied standard, recommended for more complex cases.
Typical programs run 4 to 8 weeks of regular sessions, though the exact duration depends on the specific protocol and individual response to therapy.
What actually helps
Cognitive behavioral therapy for insomnia (CBT-I)
Strong evidenceThe recommended first-line treatment, combining sleep restriction, stimulus control, and cognitive restructuring.
Sleep hygiene
Moderate evidenceBasic principles (consistent sleep times, limiting evening screens, avoiding caffeine) — helpful, but usually insufficient alone for chronic insomnia.
Pharmacological treatment
Moderate evidenceConsidered in selected cases, usually short-term or as a supplement to CBT-I, under a doctor's supervision.
What to combine with
Good combinations
Sleep — Understanding sleep physiology (stages, sleep pressure, circadian rhythm) makes it easier to understand how CBT-I works
Chronotype — Matching bedtime to your own chronotype can support the effectiveness of the behavioral techniques used in CBT-I
Melatonin — Melatonin can help with circadian rhythm disorders, but doesn't replace CBT-I in treating chronic insomnia
Safety
Side effects & contraindications
Possible side effects
Untreated chronic insomnia is linked to impaired cognitive function, mood, and daytime quality of life
Sleep restriction (a CBT-I component) can cause a temporary increase in daytime sleepiness early in therapy
Contraindications
No significant contraindications at typical doses.
Interactions
Caffeine and alcohol consumed in the second half of the day can worsen insomnia symptoms — more in our sleep entry
Irregular sleep and wake times undermine the effectiveness of the behavioral techniques used in CBT-I
Is it worth taking?
Who it's for
- People with chronic difficulty falling asleep or staying asleep, persisting for at least three months
- People for whom basic sleep hygiene has not brought lasting improvement
- People seeking a long-term alternative to sleep medication
Not for
- No significant contraindications at typical doses.
Evidence
Worth knowing
Chronic insomnia is diagnosed when symptoms occur at least 3 times a week for a minimum of 3 months.
In the Trauer et al. meta-analysis, CBT-I improved sleep efficiency by an average of nearly 10 percentage points versus control groups.
Studies
CBT-I is an effective treatment for adults with chronic insomnia, with clinically meaningful effect sizes.
Trauer JM et al., Annals of Internal Medicine, 2015 (meta-analysis of 20 trials, n=1,162)
Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis
Strong evidenceTrauer JM, Qian MY, Doyle JS, Rajaratnam SM, Cunnington D · Annals of Internal Medicine · 2015
A systematic review and meta-analysis of 20 randomized trials (1,162 participants) comparing CBT-I to control groups found clinically meaningful improvement in sleep onset latency (by 19 minutes), wake time after sleep onset (by 26 minutes), and sleep efficiency (by 9.9 percentage points), with effects sustained in long-term follow-up and no reported adverse effects.
View studySources & bibliography
Citations are illustrative for this demo version and require full bibliographic verification by the editorial team before production publication.
Compare with similar entries
About the authors of this entry
Author
dr Anna KowalczykEditor-in-Chief, Molecular Biology
Anna studied molecular biology at the University of Warsaw, then spent eight years after her PhD in a lab researching the mechanisms of cellular aging and autophagy. She stumbled into science journalism almost by accident — frustrated by how easily her field's findings get oversimplified in the media, she started a blog explaining the biology of aging in plain language. That blog became the seed of VitMode. Today Anna oversees the entire editorial process, holding every piece to the same rigor her old lab demanded: primary sources, methodology checks, and honesty about the limits of the evidence. Outside work, she's a dedicated boulderer.
196 publications on this site
Medical review
dr Marek WójcikPsychiatrist
Marek specializes in psychiatry and spent most of his career at the intersection of psychiatry and sleep medicine, watching how often mood disorders and sleep problems feed each other — and how treating them separately tends to work worse than treating them together. Julia talked him into joining, having met him while both were working on the topic of insomnia: him from the clinical side, her from chronobiology. He reviews content on how supplements and lifestyle affect mood, stress and cognitive function, always underlining the difference between easing a symptom and treating its cause, and flagging when a topic goes beyond what's safe to handle on your own. He believes the biggest risk in popular mental-health content isn't too little information but too much of it with no sense of priority — and that's the hierarchy he tries to bring to his reviews.
28 publications on this site
Related entries
4.8Sleep
Sleep isn't a passive shutdown of the body — it's an active, highly organized biological process. Its shortfall (and, counterintuitively, its excess too) is linked to a measurably higher risk of death from any cause.
4.4Chronotype
An individual, largely genetically determined preference for sleep and activity timing — ignoring it leads to a phenomenon known as 'social jet lag,' linked to worse metabolic health.
4.6Melatonin
The hormone that governs your circadian rhythm — as a supplement it works better at resetting the body clock than as a classic 'sleeping pill.'
4.7Sleep and Memory
Learning during the day is only half of the memorization process — the other half happens at night, as the brain actively consolidates and organizes newly acquired information during sleep.
4.7CBT-I (Cognitive Behavioral Therapy for Insomnia)
CBT-I is a structured, multi-component treatment program — not a single technique or a list of sleep-hygiene tips — that US and European clinical guidelines recommend as first-line treatment for chronic insomnia, ahead of sleep medication.
4.8Sleep and Growth Hormone / Cortisol Secretion
Sleep architecture — specifically the presence of deep slow-wave sleep — directly drives the largest daily pulse of growth hormone, while sleep acts as an anchor synchronizing the daily cortisol rhythm. Disrupted sleep dysregulates both systems regardless of how many hours we actually spend in bed.
4.7Sleep and Immunity
Sleep isn't just about muscle and brain recovery — it's one of the immune system's primary regulators, and even a single short night measurably changes natural killer cell activity and susceptibility to viral infection.
4.7Sleep and Mental Health
Insomnia isn't just a symptom accompanying depression or anxiety — the largest randomized intervention trial in psychiatric history showed that improving sleep directly reduces paranoia, hallucinations, anxiety, and low mood.
Related articles
PoradnikiCognitive Behavioral Therapy for Insomnia (CBT-I) — What Does a Meta-Analysis Show?
When sleep falls apart, the simplest reflex is to reach for a sleeping pill. Yet for years, international sleep medicine guidelines have pointed to a completely different approach as the first-line treatment for chronic insomnia — cognitive behavioral therapy for insomnia (CBT-I). A large meta-analysis covering 87 randomized trials and over 6,000 participants shows why that recommendation isn't arbitrary.
August 27, 2026
PoradnikiAshwagandha and Insomnia — What Did the Clinical Trial Show About Sleep Quality?
Ashwagandha is mostly associated with cortisol and stress, but one clinical trial tested something narrower and more clinical: does the same adaptogen help people with diagnosed insomnia — not just stressed, poorly-sleeping adults, but patients meeting the criteria for insomnia. A double-blind, randomized trial using actigraphy instead of questionnaires alone gives concrete numbers on shortened sleep onset and improved sleep efficiency.
August 25, 2026
PoradnikiLemon Balm (Melissa officinalis) and Anxiety or Insomnia: What Does the Evidence Actually Show?
Lemon balm (Melissa officinalis) has been brewed into calming teas for centuries, but it's only in recent years that it has gotten a systematic review of clinical trials. A 2021 meta-analysis shows a statistically significant effect on anxiety and depression symptoms — with the caveat that the number of trials is small and the quality of evidence is moderate. Evidence for lemon balm's effect on sleep itself is far thinner — what we know comes mostly from single, small clinical trials.
September 2, 2026
PoradnikiInsomnia After Quitting Caffeine: How Long It Lasts and What Helps
Caffeine withdrawal is usually pictured as headaches and fatigue, but some people also report sleep problems — a paradox, since the withdrawal mechanism should make you sleepier, not keep you awake. We explain what the research on caffeine withdrawal syndrome actually shows, why classic "insomnia" is rarer here than it seems, and what genuinely helps you get through this window.
October 3, 2026
Comments (2)
- KW
Kasia W. 2 weeks ago
Very clearly explained, especially the interactions section — I hadn't seen it laid out this well anywhere else.
- MT
Marek T. a month ago
Are you planning to update this with the newest study from this year? I saw an interesting meta-analysis.